3,4-Dimethylmethcathinone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
3,4-Dimethylmethcathinone
3,4-DMMC.svg
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
Formula C12H17NO
Molar mass 191.269 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.[1] 3,4-DMMC has been seized as a designer drug in Australia.[2]

Legal Status[edit]

As of October 2015 3,4-DMMC is a controlled substance in China.[3]

3,4-DMMC is banned in the Czech Republic.[4]

See also[edit]

References[edit]

  1. ^ EMCDDA Annual Report 2010
  2. ^ Locos, O.; Reynolds, D. (2012). "The Characterization of 3,4-Dimethylmethcathinone (3,4-DMMC)". Journal of Forensic Sciences. 57 (5): 1303–1306. doi:10.1111/j.1556-4029.2012.02142.x. PMID 22564211. 
  3. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015. 
  4. ^ "Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" (PDF) (in Czech). Ministerstvo zdravotnictví.